Blueshift Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,925
Closed -$272K 685
2022
Q2
$272K Buy
+10,925
New +$326K 0.04% 474
2020
Q1
Sell
-10,413
Closed -$384K 371
2019
Q4
$384K Buy
+10,413
New +$369K 0.04% 524

Other funds holding FMS

Blueshift Asset Management's FMS Position: Q3 2022 in Review

Blueshift Asset Management sold out of Fresenius Medical Care (FMS) in Q3 2022, closing a stake of 10,925 shares — an estimated $272K sold.

Blueshift Asset Management first reported a position in FMS in Q4 2019 and held it in 2 quarters. The position peaked at $384K in Q4 2019. 141 funds tracked by Wall St. Rank hold FMS as of Q3 2022.

  • Blueshift Asset Management reported no remaining Fresenius Medical Care position as of Q3 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 10,925 Fresenius Medical Care shares in Q3 2022, an estimated $272K.
  • Blueshift Asset Management first reported a position in Fresenius Medical Care in Q4 2019 and held it in 2 quarters.
  • Blueshift Asset Management's Fresenius Medical Care position peaked at $384K in Q4 2019.
  • 141 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2022.

Based on Blueshift Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.